2025 年克隆與誘變全球市場報告

預計未來幾年克隆和誘變市場規模將快速成長。到 2029 年，這一數字將成長至 72 億美元，複合年成長率為 19.3%。預測期內的成長可歸因於基因治療應用的不斷擴大、個性化醫療需求的不斷成長、功能基因組學的進步、合成生物學的創新以及農業生物技術的應用。預測期內的主要趨勢包括治療中的標靶基因編輯、提高精確度和特異性、可自訂的分子工具、擴大農業中的應用以及道德和監管考慮。

由於對基因改造產品的需求不斷增加，克隆和誘變市場預計將成長。基因改造產品包括經過故意基因改造以引入新特性或特徵的生物、材料或物質。克隆是產生精確基因副本的科學過程，具有多種用途，包括創造抗性昆蟲和植物品種以及促進醫學中的基因治療。根據德國生物技術和製藥公司Bayar AG的年度報告，基因改造產品的銷售額正在大幅成長，作物科學領域的銷售額預計將從2021年的223.1479億美元成長到2022年的277.9438億美元。對此類基因改造產品的需求不斷成長，是克隆和誘變市場的主要驅動力。這些資料是根據拜耳股份公司 2023 年 2 月發布的年度報告中提供的資訊。

由於個人化醫療需求的不斷增加，克隆和誘變市場預計將成長。個人化醫療是一種創新的醫療保健方法，根據每個患者的特徵量身定做治療和干涉措施。克隆和誘變在個人化醫療的許多方面發揮關鍵作用，包括疾病建模、藥物開發、標靶識別、基因治療、生物標記發現、患者特異性細胞治療、藥物基因組學和個人化治療的基因組編輯。 2022年4月，精準醫學聯盟報告稱，美國食品藥物管理局（FDA）藥品評估和研究中心（CDER）在2022年核准了37個新分子實體（NME）。在治療性NME中，約有34%（其中12個）被個人化醫療聯盟（PMC）歸類為個人化醫療。對個人化醫療日益成長的需求是複製和誘變市場成長的主要驅動力。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 世界克隆與誘變PESTEL分析（政治、社會、科技、環境、法律因素、促進因素、限制因素）
• 最終用途產業分析
• 全球克隆與誘變市場：成長率分析
• 全球克隆和誘變市場表現：規模和成長，2019 年至 2024 年
• 全球克隆和誘變市場預測：規模和成長，2024-2029 年，2034 年預測
• 全球複製和誘變總目標市場 (TAM)

第6章 市場細分

• 全球克隆與誘變市場：按產品、績效和預測，2019-2024 年、2024-2029 年、2034 年
• 克隆試劑套件
• 誘變試劑套件
• 其他產品
• 全球克隆和誘變市場（按技術、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 平端克隆
• TopoPCR 克隆
• 無縫克隆
• 定點突變
• 其他技術
• 全球克隆和誘變市場（按最終用戶、業績和預測），2019-2024 年、2024-2029 年、2034 年
• 學術研究所
• 生技公司
• 其他最終用戶
• 全球克隆和誘變市場細分（按克隆試劑套件類型、實際和預測），2019-2024 年、2024-2029 年、2034 年
• 細菌克隆試劑套件
• 酵母克隆試劑套件
• 病毒克隆試劑套件
• 質體克隆試劑套件
• 全球克隆和誘變市場，按誘變試劑套件類型細分，性能和預測，2019-2024 年，2024-2029 年，2034 年
• 定點突變套件
• 隨機誘變試劑套件
• 易錯 PCR 試劑套件
• CRISPR 或 Cas9 誘變試劑套件
• 全球克隆和誘變市場、其他產品細分、按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 酵素
• 向量系統
• 配件

第7章 區域和國家分析

• 全球克隆與誘變市場：按地區、績效和預測，2019-2024 年、2024-2029 年、2034 年
• 全球克隆與誘變市場：按國家、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

• 克隆與誘變市場：競爭格局
• 克隆和誘變市場：公司簡介
  • Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
  • Takara Bio Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Jena Bioscience GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Transgen Biotech Co Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• New England Biolabs
• Merck KGaA
• Promega Corporation
• Bio-Rad Laboratories Inc.
• Danaher
• Genomax Technologies Pte Ltd
• GENEWIZ Inc.
• abm Inc.
• GenScript
• EZBioscience
• Codex DNA Inc.
• Aragen Life Sciences
• Bio-Techne
• Charles River Laboratories
• Integrated DNA Technologies

第 32 章 全球市場競爭基準化分析與儀表板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029 年克隆與誘變市場：提供新機會的國家
• 2029 年克隆與誘變市場：提供新機會的細分市場
• 克隆和誘變市場 2029：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第 36 章 附錄

Cloning and mutagenesis are integral techniques within molecular biology that involve the replication of multiple identical copies of a DNA fragment, gene, or entire genome, along with the introduction of mutations into a DNA sequence. These techniques play a crucial role in studying gene function and regulation, facilitating the development of new drugs and therapeutics, and producing recombinant enzymes and proteins.

The primary products associated with cloning and mutagenesis include cloning kits, mutagenesis kits, and other related tools. Cloning kits are specialized laboratory instruments designed to streamline the process of cloning specific DNA fragments or genes into a cloning vector. These kits are essential for various cloning experiments, including gene cloning, subcloning, site-directed mutagenesis, and library construction. Techniques such as blunt end cloning, topo PCR cloning, seamless cloning, site-directed mutagenesis, among others, are employed by academic and research institutions, biotechnology companies, and other entities engaged in molecular biology research.

The cloning and mutagenesis software market research report is one of a series of new reports from The Business Research Company that provides cloning and mutagenesis software market statistics, including cloning and mutagenesis software industry global market size, regional shares, competitors with a cloning and mutagenesis software market share, detailed cloning and mutagenesis software market segments, market trends and opportunities, and any further data you may need to thrive in the cloning and mutagenesis software industry. This cloning and mutagenesis software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cloning and mutagenesis market size has grown rapidly in recent years. It will grow from$2.98 billion in 2024 to $3.56 billion in 2025 at a compound annual growth rate (CAGR) of 19.5%. The growth in the historic period can be attributed to advancements in genetic research, increasing demand in pharmaceutical research, rise of genetic engineering in agriculture, biomedical research applications, pioneer applications in molecular biology

The cloning and mutagenesis market size is expected to see rapid growth in the next few years. It will grow to $7.2 billion in 2029 at a compound annual growth rate (CAGR) of 19.3%. The growth in the forecast period can be attributed to expanding applications in gene therapy, rising demand for personalized medicine, advancements in functional genomics, innovations in synthetic biology, application in agricultural biotechnology. Major trends in the forecast period include targeted gene editing in therapeutics, enhanced precision and specificity, customizable molecular tools, expanded applications in agriculture, ethical and regulatory considerations.

The cloning and mutagenesis market is expected to experience growth driven by the rising demand for genetically modified products. Genetically modified products involve organisms, materials, or substances that undergo deliberate genetic engineering to introduce new traits or characteristics. Cloning, a scientific process for producing exact genetic copies, is utilized in various applications, including creating insect and plant-resistant species and facilitating gene therapy in medical sciences. An annual report from Bayar AG, a Germany-based biotechnology and pharmaceutical company, revealed significant growth in the sales of genetically modified products, with the crop sciences segment reaching $27,794.38 million in 2022, up from $22,314.79 million in 2021. This increased demand for genetically modified products is a key driver of the cloning and mutagenesis market. The data is based on information provided in the annual report published by Bayar AG in February 2023.

The cloning and mutagenesis market is anticipated to grow due to the increasing demand for personalized medicine. Personalized medicine is an innovative healthcare approach that tailors medical treatment and interventions to the unique characteristics of each patient. Cloning and mutagenesis play crucial roles in various aspects of personalized medicine, such as disease modeling, drug development, target identification, gene therapy, biomarker discovery, patient-specific cell therapies, pharmacogenomics, and genome editing for personalized therapies. In April 2022, the Personalized Medicine Coalition reported that the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Among the therapeutic NMEs, approximately 34% (12 of them) were classified as personalized medicines by the Personalized Medicine Coalition (PMC). This increasing demand for personalized medicine is a significant driver of the growth in the cloning and mutagenesis market.

Major players in the cloning and mutagenesis market are leveraging advanced technologies, such as bacteriophage genome modifying technologies, to enhance their competitive position. Bacteriophage genome modifying technologies involve intentional alterations to the genetic material of bacteriophages, viruses that infect bacteria, for applications in research, therapy, or industry. An example is iNtRON Biotechnology, a South Korea-based biotech company, which introduced its 2nd generation Robot Bacteriophage technology in October 2022. This technology utilizes random transposon mutagenesis to modify the bacteriophage genome, enabling the identification and removal of non-essential genes. iNtRON aims to design and produce bacteriophages with specific characteristics, facilitating the development of immunotherapeutic agents and antiviral solutions.

Leading companies in the cloning and mutagenesis markets are also actively exploring innovative techniques such as Polymerase Chain Reaction (PCR) to maintain a competitive edge. PCR is a molecular biology laboratory technique that amplifies specific DNA segments. Bio-Rad Laboratories, Inc., a US-based biotech company, launched the ID-Check Speciation Solution in April 2023. This real-time PCR method aids in meat speciation, allowing the identification of animal species in food, feed, and environmental samples. It provides a reliable and rapid means to verify raw material origins, enhancing production line cleaning processes. The solution targets mitochondrial DNA from various meat species with exceptional sensitivity, detecting DNA concentrations as low as 0.001%. It features a duplex detection system for accuracy and user convenience.

In May 2022, QIAGEN N.V., a Netherlands-based provider of sample and assay technologies, acquired BLIRT SA for an undisclosed amount. This acquisition is intended to bolster QIAGEN's capabilities in developing innovative molecular diagnostics and biopharmaceutical solutions. BLIRT SA, a manufacturer based in Poland, specializes in recombinant enzymes used for molecular cloning and site-directed mutagenesis.

Major companies operating in the cloning and mutagenesis market include Thermo Fisher Scientific, Takara Bio Inc., Agilent Technologies Inc., Jena Bioscience GmbH, Transgen Biotech Co, New England Biolabs, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc., Danaher, Genomax Technologies Pte Ltd, GENEWIZ Inc., abm Inc., GenScript, EZBioscience, Codex DNA Inc., Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Integrated DNA Technologies, MedGenome, Sino Biological Inc., BioChain Institute Inc., OriGene Technologies Inc., Creative Biogene, Bioneer Corporation, Synbio Technologies LLC, Lucigen Corporation, Biomatik Corporation, Quanta BioDesign Ltd., Inscripta Inc.

North America was the largest region in the cloning and mutagenesis market in 2024. Asia-pacific is expected to be the fastest-growing region in the global cloning and mutagenesis market report during the forecast period. The regions covered in the cloning and mutagenesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cloning and mutagenesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cloning and mutagenesis market includes revenues earned by entities by assay kits, biotin-peg linkers, Bira proteins, and cells. The market value includes the value of related goods sold by the service provider or included within the service offering. The cloning and mutagenesis market also includes of sales of techniques such as the isolation of DNA, cloning vectors, and DNA ligase. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cloning And Mutagenesis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cloning and mutagenesis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cloning and mutagenesis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cloning and mutagenesis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Cloning Kits; Mutagenesis Kits; Other Product
• 2) By Technique: Blunt End Cloning; Topo PCR Cloning; Seamless Cloning; Site-Directed Mutagenesis; Other Techniques
• 3) By End User: Academic and Research Institutes; Biotechnology Companies; Other End User
• Subsegments:
• 1) By Cloning Kits: Bacterial Cloning Kits; Yeast Cloning Kits; Viral Cloning Kits; Plasmid Cloning Kits
• 2) By Mutagenesis Kits: Site-Directed Mutagenesis Kits; Random Mutagenesis Kits; Error-Prone PCR Kits; CRISPR Or Cas9 Mutagenesis Kits
• 3) By Other Products: Enzymes; Vector Systems; Accessories
• Companies Mentioned: Thermo Fisher Scientific; Takara Bio Inc.; Agilent Technologies Inc.; Jena Bioscience GmbH; Transgen Biotech Co
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cloning And Mutagenesis Market Characteristics

3. Cloning And Mutagenesis Market Trends And Strategies

4. Cloning And Mutagenesis Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Cloning And Mutagenesis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cloning And Mutagenesis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cloning And Mutagenesis Market Growth Rate Analysis
• 5.4. Global Cloning And Mutagenesis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cloning And Mutagenesis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cloning And Mutagenesis Total Addressable Market (TAM)

6. Cloning And Mutagenesis Market Segmentation

• 6.1. Global Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cloning Kits
• Mutagenesis Kits
• Other Product
• 6.2. Global Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blunt End Cloning
• Topo PCR Cloning
• Seamless Cloning
• Site-Directed Mutagenesis
• Other Techniques
• 6.3. Global Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic and Research Institutes
• Biotechnology Companies
• Other End User
• 6.4. Global Cloning And Mutagenesis Market, Sub-Segmentation Of Cloning Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacterial Cloning Kits
• Yeast Cloning Kits
• Viral Cloning Kits
• Plasmid Cloning Kits
• 6.5. Global Cloning And Mutagenesis Market, Sub-Segmentation Of Mutagenesis Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Site-Directed Mutagenesis Kits
• Random Mutagenesis Kits
• Error-Prone PCR Kits
• CRISPR Or Cas9 Mutagenesis Kits
• 6.6. Global Cloning And Mutagenesis Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzymes
• Vector Systems
• Accessories

7. Cloning And Mutagenesis Market Regional And Country Analysis

• 7.1. Global Cloning And Mutagenesis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cloning And Mutagenesis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cloning And Mutagenesis Market

• 8.1. Asia-Pacific Cloning And Mutagenesis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cloning And Mutagenesis Market

• 9.1. China Cloning And Mutagenesis Market Overview
• 9.2. China Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cloning And Mutagenesis Market

• 10.1. India Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cloning And Mutagenesis Market

• 11.1. Japan Cloning And Mutagenesis Market Overview
• 11.2. Japan Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cloning And Mutagenesis Market

• 12.1. Australia Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cloning And Mutagenesis Market

• 13.1. Indonesia Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cloning And Mutagenesis Market

• 14.1. South Korea Cloning And Mutagenesis Market Overview
• 14.2. South Korea Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cloning And Mutagenesis Market

• 15.1. Western Europe Cloning And Mutagenesis Market Overview
• 15.2. Western Europe Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cloning And Mutagenesis Market

• 16.1. UK Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cloning And Mutagenesis Market

• 17.1. Germany Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cloning And Mutagenesis Market

• 18.1. France Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cloning And Mutagenesis Market

• 19.1. Italy Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cloning And Mutagenesis Market

• 20.1. Spain Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cloning And Mutagenesis Market

• 21.1. Eastern Europe Cloning And Mutagenesis Market Overview
• 21.2. Eastern Europe Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cloning And Mutagenesis Market

• 22.1. Russia Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cloning And Mutagenesis Market

• 23.1. North America Cloning And Mutagenesis Market Overview
• 23.2. North America Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cloning And Mutagenesis Market

• 24.1. USA Cloning And Mutagenesis Market Overview
• 24.2. USA Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cloning And Mutagenesis Market

• 25.1. Canada Cloning And Mutagenesis Market Overview
• 25.2. Canada Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cloning And Mutagenesis Market

• 26.1. South America Cloning And Mutagenesis Market Overview
• 26.2. South America Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cloning And Mutagenesis Market

• 27.1. Brazil Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cloning And Mutagenesis Market

• 28.1. Middle East Cloning And Mutagenesis Market Overview
• 28.2. Middle East Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cloning And Mutagenesis Market

• 29.1. Africa Cloning And Mutagenesis Market Overview
• 29.2. Africa Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cloning And Mutagenesis Market Competitive Landscape And Company Profiles

• 30.1. Cloning And Mutagenesis Market Competitive Landscape
• 30.2. Cloning And Mutagenesis Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Takara Bio Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Jena Bioscience GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Transgen Biotech Co Overview, Products and Services, Strategy and Financial Analysis

31. Cloning And Mutagenesis Market Other Major And Innovative Companies

• 31.1. New England Biolabs
• 31.2. Merck KGaA
• 31.3. Promega Corporation
• 31.4. Bio-Rad Laboratories Inc.
• 31.5. Danaher
• 31.6. Genomax Technologies Pte Ltd
• 31.7. GENEWIZ Inc.
• 31.8. abm Inc.
• 31.9. GenScript
• 31.10. EZBioscience
• 31.11. Codex DNA Inc.
• 31.12. Aragen Life Sciences
• 31.13. Bio-Techne
• 31.14. Charles River Laboratories
• 31.15. Integrated DNA Technologies

32. Global Cloning And Mutagenesis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cloning And Mutagenesis Market

34. Recent Developments In The Cloning And Mutagenesis Market

35. Cloning And Mutagenesis Market High Potential Countries, Segments and Strategies

• 35.1 Cloning And Mutagenesis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cloning And Mutagenesis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cloning And Mutagenesis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer